Murray Potter
Overview
Explore the profile of Murray Potter including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
24
Citations
364
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Paik K, Lines M, Chakraborty P, Khangura S, Latocki M, Al-Hertani W, et al.
Can J Neurol Sci
. 2019 Aug;
46(6):717-726.
PMID: 31387656
Background: An improved understanding of diagnostic and treatment practices for patients with rare primary mitochondrial disorders can support benchmarking against guidelines and establish priorities for evaluative research. We aimed to...
12.
Fleming L, Oliver J, Potter M, Kam A
Paediatr Child Health
. 2019 May;
24(3):146-147.
PMID: 31110452
No abstract available.
13.
Karaceper M, Khangura S, Wilson K, Coyle D, Brownell M, Davies C, et al.
Orphanet J Rare Dis
. 2019 Mar;
14(1):70.
PMID: 30902101
Background: We describe early health services utilization for children diagnosed with medium-chain acyl-CoA dehydrogenase (MCAD) deficiency through newborn screening in Ontario, Canada, relative to a screen negative comparison cohort. Methods:...
14.
Hannah-Shmouni F, MacNeil L, Potter M, Jobling R, Yoon G, Laughlin S, et al.
Mol Genet Metab Rep
. 2019 Jan;
18:11-13.
PMID: 30619713
Newborns with cystic degeneration with or without intractable seizures should be investigated for inborn errors of metabolism, including molybdenum cofactor deficiency (MoCoD). MoCoD may present with non-specific hypoxic ischemic injury...
15.
Mattman A, Potter M
Rev Endocr Metab Disord
. 2018 Jul;
19(1):5-12.
PMID: 30032338
Endocrinologists may encounter abnormal results in routine laboratory tests while caring for patients with inborn errors of metabolism. This article provides a framework for understanding these abnormalities as: a) part...
16.
Gannavarapu S, Prasad C, DiRaimo J, Napier M, Goobie S, Potter M, et al.
Mol Genet Metab
. 2015 Sep;
116(3):146-51.
PMID: 26361991
Untreated profound biotinidase deficiency results in a wide range of clinical features, including optic atrophy, cutaneous abnormalities, hearing loss and developmental delay. Ontario, Canada incorporated this treatable deficiency in newborn...
17.
Metabolic Clinic Atlas: Organization of Care for Children with Inherited Metabolic Disease in Canada
Lamoureux M, Tingley K, Kronick J, Potter B, Chan A, Coyle D, et al.
JIMD Rep
. 2015 Feb;
21:15-22.
PMID: 25716610
Introduction: Nearly all children in Canada with an inherited metabolic disease (IMD) are treated at one of the country's Hereditary Metabolic Disease Treatment Centres. We sought to understand the system...
18.
Khan A, Ho J, Pender A, Wei X, Potter M
Clin Pediatr Endocrinol
. 2014 May;
17(3):81-5.
PMID: 24790368
A severe form of I-cell disease (mucolipidosis II) can present in the newborn period as multiple fractures. The bone disease in these patients is believed to be due to hyperparathyroidism....
19.
Gunz A, Choong K, Potter M, Miller E
Int Med Case Rep J
. 2013 Aug;
6:41-8.
PMID: 23983495
The urea-cycle functions to facilitate ammonia excretion, a disruption of which results in the accumulation of toxic metabolites. The neurological outcome of neonatal-onset urea-cycle defects (UCDs) is poor, and there...
20.
Bercik P, Verdu E, Foster J, Macri J, Potter M, Huang X, et al.
Gastroenterology
. 2010 Jul;
139(6):2102-2112.e1.
PMID: 20600016
Background & Aims: Clinical and preclinical studies have associated gastrointestinal inflammation and infection with altered behavior. We investigated whether chronic gut inflammation alters behavior and brain biochemistry and examined underlying...